Cleared Traditional

K232216 - Hemoblock_S (Prescription) (FDA 510(k) Clearance)

Also includes:
Hemoblock_S (OTC)
Apr 2024
Decision
268d
Days
-
Risk

K232216 is an FDA 510(k) clearance for the Hemoblock_S (Prescription). This device is classified as a Hemostatic Wound Dressing Without Thrombin Or Other Biologics.

Submitted by Incore Co., Ltd. (Daegu, KR). The FDA issued a Cleared decision on April 19, 2024, 268 days after receiving the submission on July 26, 2023.

This device falls under the General & Plastic Surgery FDA review panel. To Temporarily Control Bleeding And Cover External Wounds..

Submission Details

510(k) Number K232216 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 2023
Decision Date April 19, 2024
Days to Decision 268 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QSY - Hemostatic Wound Dressing Without Thrombin Or Other Biologics
Device Class -
Definition To Temporarily Control Bleeding And Cover External Wounds.